WT
DXCM icon

Washington Trust’s DexCom DXCM Stock Holding History

Washington Trust’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6
Closed -$402 – 860
2024
Q3 		$402 Hold
6
– – ﹤0.01% 836
2024
Q2 		$680 Buy
+6
New +$759 ﹤0.01% 848
2023
Q4 		– Sell
-110
Closed -$10.3K – 863
2023
Q3 		$10.3K Buy
110
+3
+3% +$338 ﹤0.01% 622
2023
Q2 		$13.8K Sell
107
-3
-3% -$363 ﹤0.01% 612
2023
Q1 		$12.8K Sell
110
-4
-4% -$448 ﹤0.01% 628
2022
Q4 		$12.9K Buy
114
+1
+0.9% +$110 ﹤0.01% 619
2022
Q3 		$9K Sell
113
-7
-6% -$593 ﹤0.01% 656
2022
Q2 		$9K Buy
120
+8
+7% +$730 ﹤0.01% 656
2022
Q1 		$14K Buy
112
+48
+75% +$5.25K ﹤0.01% 636
2021
Q4 		$9K Sell
64
-28
-30% -$4.02K ﹤0.01% 683
2021
Q3 		$13K Hold
92
– – ﹤0.01% 749
2021
Q2 		$10K Buy
+92
New +$8.84K ﹤0.01% 779

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Washington Trust's DXCM Position: Q4 2024 in Review

Washington Trust sold out of DexCom (DXCM) in Q4 2024, closing a stake of 6 shares — an estimated $402 sold.

Washington Trust first reported a position in DXCM in Q2 2021 and held it in 12 quarters. The position peaked at $14K in Q1 2022. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Washington Trust reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Washington Trust sold 6 DexCom shares in Q4 2024, an estimated $402.
  • Washington Trust first reported a position in DexCom in Q2 2021 and held it in 12 quarters.
  • Washington Trust's DexCom position peaked at $14K in Q1 2022.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Washington Trust's 13F filing for Q4 2024, filed 30 Jan 2025.